View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Friday, August 14, 2020**

[link removed]

****

As scientists and clinicians race to develop effective treatments to
improve survival from COVID-19 and a vaccine to control the SARS-CoV-2
virus, Health Affairs has launched a new project to help identify for
policy makers the critical decisions they will face that will have a
substantial effect on whether and how quickly society reaps the benefits
of these advances.

You are invited to join us on Monday, August 24, for a virtual symposium
when some of the top minds in the field will join Health Affairs
Editor-in-Chief Alan Weil for a discussion of these issues. Segments
will focus on "Innovation" and "Equitable Access to Vaccines and
Therapeutics."

**Featuring:**

****
* Margaret A. Hamburg, Former Commissioner, US Food and Drug
Administration

* Orin Levine, Director, Global Delivery Programs, Bill & Melinda Gates
Foundation

*

**Rena M. Conti**, Dean's Research Scholar, Questrom School of
Business, Boston University; Associate Professor, Markets, Public
Policy, And Law; Associate Research Director, Institute For Health
System Innovation And Policy

*

**Mark Feinberg**, President and CEO, IAVI

*

**Garth Graham**, Vice President and Chief Community Health Officer, CVS
Health

*

**Nicole Lurie,** Strategic Adviser to the CEO, CEPI; Senior Lecturer,
Harvard Medical School; and former Assistant Secretary for Preparedness
and Response (ASPR), US Department of Health and Human Services

*

**Angela K. Shen**, Visiting Research Scientist, Vaccine Education
Center, Children's Hospital of Philadelphia, and Captain (Ret.), US
Public Health Services

*

**Rebecca Lynn Weintraub,**Assistant Professor of Medicine, Assistant
Professor of Global Health and Social Medicine, Harvard Medical School

*

**Gavin Mark Yamey**, Professor, Practice of Global Health, Sanford
School of Public Policy, Duke University

*

**Others to be announced**

****

**Health Affairs** is grateful to the following sponsors for their
support of this work and this symposium:  Anthem, Inc., Amgen Inc.,
Avalere, Kaiser Permanente, Pharmaceutical Research and Manufacturers of
America (PhRMA), Gilead Sciences, McKesson, Quest Diagnostics, Dynavax,
Alexion, and Danaher.

RSVP TO ATTEND

TODAY ON THE BLOG

COVID-19

Moving On From Telehealth-By-Desperation: What Will Make Telehealth
Stick

By Lori Uscher-Pines

While many providers have found telehealth ideal for improving access to
care during the pandemic, telehealth visits are already declining and
may continue to decline. Without permanent policy changes, it is unclear
if telehealth services will represent a significant proportion of US
health care visits in the long run. Read More >>

POLITICS

Democrats Will Adopt Their Health Care Platform Next Week-Here's
What It Says

By Billy Wynne

The platform reiterates some hallmarks of Democratic philosophy while
addressing current challenges like the COVID-19 pandemic and adding new
details to long-sought policy goals, such as a public option. Read More
>>

IN THE JOURNAL

RESEARCH ARTICLE: WOMEN'S HEALTH

Compared With Other Countries, Women In The US Are More Likely Than Men
To Forgo Medicines Because Of Cost

By Jamie R. Daw and Michael R. Law  

Nonadherence to prescription medicines because of cost is associated
with adverse clinical outcomes. Jamie Daw and Michael Law find that in
eleven high-income countries, the largest disparities in nonadherence
for women compared with men occur in the US, Canada, and Australia,
which are among the countries in which out-of-pocket spending for
pharmaceuticals is the highest. Read More >>

Read the August 2020 Table of Contents
.

Subscribe to Health Affairs for full journal access.

**A CLOSER LOOK**-Patient-Facing Digital Technologies

The boon of digital health has yet to be seen to its full effect in
regard to delivery systems for patients. There is a clear public demand
for such options, but still health care organizations are slow to
respond. Why is that and what can be done? Read Saira Ghafur and Eric C.
Schneider's 2019 blog post.

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I